Home » Adams Respiratory to Be Acquired for $2.3 Billion
Adams Respiratory to Be Acquired for $2.3 Billion
Drug maker Adams Respiratory Therapeutics Inc., maker of Mucinex, said Monday it would be acquired by Reckitt Benckiser Group for $2.3 billion, as the household-products company seeks to broaden its footprint in consumer healthcare.
MarketWatch
MarketWatch
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May